Bangladesh

Bangladesh is rapidly emerging as a global hub for the life sciences ecosystem, primarily driven by its robust pharmaceutical industry, which supplies high-quality, generic medicines to over 160 countries.

The country is best known for its self-sufficiency in medicine production, with leading manufacturers like Square Pharmaceuticals and Beximco Pharma leveraging advanced biomanufacturing facilities that meet stringent international standards.

Beyond traditional pills, the sector is pivoting toward biotechnology and the production of complex biosimilars, vaccines and oncology drugs to address global health challenges.

The medical device market in Bangladesh is also witnessing a shift from import-reliance to local assembly, specifically in diagnostic equipment and minimally invasive surgical tools.

Healthcare innovation is being accelerated by the "Smart Bangladesh" initiative, which integrates digital health solutions and AI-driven diagnostics into the public and private healthcare framework.

On the academic front, academic research and clinical trials are gaining momentum, supported by institutions like the ICDDR,B, which is world-renowned for its contributions to infectious disease research.

This growing life sciences hub offers lucrative opportunities for international investors interested in contract manufacturing (CDMO) and R&D collaborations.

With a favorable regulatory environment and a massive domestic market, Bangladesh is positioning itself as a vital link in the global healthcare supply chain.